iKang Healthcare

iKang Healthcare CEO Zhang Ligang’s recent remarks questioning the predictive capabilities of general health screenings have sparked controversy. Zhang stated that routine check-ups are opportunistic and cannot reliably predict specific future cancer diagnoses, citing the lack of reliable tumor markers for early kidney cancer detection. This viewpoint has been criticized, with some questioning the value of screenings. iKang has responded, claiming Zhang’s comments were selectively reported and his words were distorted, damaging the company’s reputation.

A woman, Zhang Xiaoling, claims iKang Healthcare Group misdiagnosed or missed her kidney cancer diagnosis after ten years of “normal” health check-ups. She received a cancer diagnosis in 2024 at another facility. iKang states its reports were accurate at the time and will engage third-party experts to investigate. They pledge to accept responsibility if liable. Observers emphasize the importance of accurate and reliable health check-ups. iKang is a company established in 2004, focusing on hospital management and health consulting.